PAWR and familial pancreatic carcinoma: Recently, Katoch et al. have demonstrated that Par-4 actively participates in directing various events in inhibiting EMT or facilitating mesenchymal-epithelial transition (MET; the reverse process to EMT) in metastatic pancreatic cancer cells90.